MedTrace Logo

The Effect of Listening to Qur'an Recital on Quality of Life in Systemic Lupus Erythematosus Patients

NCT06263764 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-02-16

No results posted yet for this study

Summary

The goal of this quasi-experimental study is to evaluate the effect of listening to the Qur'an recital on quality of life among systemic lupus erythematosus patients. There will be intervention and control groups. Before the intervention, the quality of life of participants will be assessed using the Lupus-QoL questionnaire. After the baseline assessment, participants in the intervention group will be asked to listen to a Qur'an recital by Surah Ar-Rahman using an MP3 player twice a day for a minimum of 15 minutes each for 40 days. The control group will not receive any specific intervention and will continue with their usual routine. After the 40-day intervention period, the quality of life of participants in both groups will be assessed using the Lupus-QoL questionnaire. The results will be analyzed to determine if there is a significant improvement in quality of life. Besides, potential confounding factors such as SLE clinical manifestations, disease activity, pharmacologic treatment regimen, anxiety/depression, comorbidities, age, and economic status will also be collected before and after intervention to evaluate its effect on the quality of life.

Conditions

  • Quality of Life

Interventions

OTHER

Listening to Qur'an Recital

Listening to Surah Ar Rahman twice a day for minimum 15 minutes each for 40 days

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Rudi Putranto, PhD · Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  • Sukamto Koesnoe, PhD · Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  • Alvina Widhani, PhD · Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  • Karina Wijayanti, MD · Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-06-30
Completion
2024-07-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06263764 on ClinicalTrials.gov